Compare HLNE & ICUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HLNE | ICUI |
|---|---|---|
| Founded | 1991 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6B | 3.6B |
| IPO Year | 2017 | 1995 |
| Metric | HLNE | ICUI |
|---|---|---|
| Price | $103.29 | $179.34 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 3 |
| Target Price | $156.78 | ★ $169.00 |
| AVG Volume (30 Days) | ★ 748.5K | 327.6K |
| Earning Date | 05-21-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.44% | N/A |
| EPS Growth | 41.64 | ★ 100.62 |
| EPS | ★ 3.98 | 1.96 |
| Revenue | $758,993,000.00 | ★ $2,231,262,000.00 |
| Revenue This Year | $9.69 | N/A |
| Revenue Next Year | $15.81 | $4.46 |
| P/E Ratio | ★ $26.34 | $92.90 |
| Revenue Growth | ★ 6.46 | N/A |
| 52 Week Low | $71.88 | $111.42 |
| 52 Week High | $159.87 | $192.85 |
| Indicator | HLNE | ICUI |
|---|---|---|
| Relative Strength Index (RSI) | 71.96 | 63.72 |
| Support Level | $90.31 | $136.56 |
| Resistance Level | $105.34 | N/A |
| Average True Range (ATR) | 3.84 | 5.28 |
| MACD | 1.39 | 0.93 |
| Stochastic Oscillator | 89.76 | 59.46 |
Hamilton Lane Inc is a private markets investment firm globally, providing solutions to institutional and private wealth investors around the world. Dedicated exclusively to private markets investing for more than 30 years, the firm currently employs approximately 750 professionals operating in offices throughout North America, Europe, Asia Pacific, and the Middle East. It has approximately $986 billion in assets under management and supervision, composed of nearly $141 billion in discretionary assets and more than $845 billion in non-discretionary assets. The group specializes in building flexible investment programs that provide clients access to the full spectrum of private markets strategies, sectors, and geographies.
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.